Molecular Characterisation of Long-Acting Insulin Analogues in Comparison with Human Insulin, IGF-1 and Insulin X10

Engineering of Insulin Receptor Isoform-Selective Insulin Analogues

(2011) Tine Glendorf et al.   PLoS One

Doses of Insulin and Its Analogues and Cancer Occurrence in Insulin-Treated Type 2 Diabetic Patients

(2010) E. Mannucci et al.   DIABETES CARE

Insulin detemir is a fully efficacious, low affinity agonist at the insulin receptor

(2010) A. R. Sørensen et al.   DIABETES OBESITY & METABOLISM

Appraising the mitogenicity of insulin analogues relative to human insulin-response to: Weinstein D, Simon M, Yehezkel E, Laron Z, Werner H. Insulin analogues display IGF-I-like mitogenic and anti-apoptotic activity in cultured cancer cells. Diabetes Meta

(2010) C. Kazda et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Long-acting insulin analogues elicit atypical signalling events mediated by the insulin receptor and insulin-like growth factor-I receptor

(2010) E. Yehezkel et al.   DIABETOLOGIA

Insulin analogues differently activate insulin receptor isoforms and post-receptor signalling

(2010) L. Sciacca et al.   DIABETOLOGIA

Insulin glargine is more potent in activating the human IGF-I receptor than human insulin and insulin detemir

(2010) A.J. Varewijck et al.   GROWTH HORMONE & IGF RESEARCH

Insulin analogues and cancer risk: cause for concern orcause célèbre?

(2010) M. Pollak et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

In Vitro Metabolic and Mitogenic Signaling of Insulin Glargine and Its Metabolites

(2010) Mark R. Sommerfeld et al.   PLoS One

Synchronization in G0/G1 enhances the mitogenic response of cells overexpressing the human insulin receptor A isoform to insulin

(2009) Christine Bonnesen et al.   CELL BIOLOGY AND TOXICOLOGY

Insulin analogues display IGF-I-like mitogenic and anti-apoptotic activities in cultured cancer cells

(2009) Doron Weinstein et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Insulin glargine use and short-term incidence of malignancies—a population-based follow-up study in Sweden

(2009) J. M. Jonasson et al.   DIABETOLOGIA

Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group

(2009) H. M. Colhoun et al.   DIABETOLOGIA

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

(2009) C. J. Currie et al.   DIABETOLOGIA

Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study

(2009) L. G. Hemkens et al.   DIABETOLOGIA

Insulin Receptor Isoforms and Insulin Receptor/Insulin-Like Growth Factor Receptor Hybrids in Physiology and Disease

(2009) Antonino Belfiore et al.   ENDOCRINE REVIEWS

Analysis of signaling pathways related to cell proliferation stimulated by insulin analogs in human mammary epithelial cell lines

(2009) Ashish Shukla et al.   ENDOCRINE-RELATED CANCER

Insulin glargine and malignancy: an unwarranted alarm

(2009) Stuart J Pocock et al.   LANCET

Importance of the Solvent-Exposed Residues of the Insulin B Chain α-Helix for Receptor Binding†

(2008) Tine Glendorf et al.   BIOCHEMISTRY

Insulin Analogues with Increased Mitogenic Potency - Are they Safe?

(2008) B. Hansen   HORMONE AND METABOLIC RESEARCH